A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD.
Gary TseBenjamin EmmanuelCono AritiMona BafadhelAlberto PapiVictoria Ann CarterJiandong ZhouDerek SkinnerXiao XuHana MullerovaDavid J PricePublished in: International journal of chronic obstructive pulmonary disease (2023)
Any OCS use was associated with higher risk of adverse outcomes in patients with COPD, with risk generally increasing with greater cumulative OCS dose.